WebCytarabine. Cytarabine is a chemotherapy medicine used to treat certain types of cancer and leukaemia. This page explains what cytarabine is, how it is given and some of the possible side effects. Each person reacts differently to medicines, so your child will not necessarily suffer from every side effect mentioned. WebJul 22, 2024 · ROB HOLLAND Aircraft: MX-2. Over the years, Rob completely immersed himself in aviation, spending time as a corporate, commuter, and ferry pilot, a banner tower, and a flight instructor, all while running his own aerobatic school. He is the only pilot to ever have achieved the titles of five-time, consecutive World Four-Minute Freestyle ...
CYTARABINE - Welcome to RobHolland.com
WebAcute non-lymphocytic leukemia in adults and children. Cytarabine is also approved to prevent and treat: Meningeal leukemia ( leukemia that has spread to the meninges ). It is given as intrathecal therapy. Cytarabine may also be used to treat: Acute lymphoblastic leukemia (ALL). Chronic myelogenous leukemia (CML) in blastic phase. WebNov 24, 2024 · Cytarabine may cause serious side effects. Call your doctor at once if you have: severe drowsiness, confusion, unusual thoughts or behavior; fever, chills, body aches, feeling very ill; stomach pain, bloating, nausea, vomiting, bloody or tarry stools; loss of movement in any part of your body; liver problems--loss of appetite, right-sided upper ... portchester castle to salt cafe
Cytarabine Injection Solution 100 mg/ml - Summary of Product ...
CYTARABINE (sye-tare'a-been) ARA-C, Cytosar-U, Cytosine Arabinoside, DepoCyt, Tarabine Classifications:antineoplastic; antimetabolite, purine antagonist; immunosuppressant Prototype: 6-mercaptopurine Pregnancy Category: D Availability 10 mg/mL liposomal, 20 mg/mL, 100 mg, 500 mg, 1g, 2 g injection … See more Pyrimidine analog with cell phase specificity affecting rapidly dividing cells in S phase (DNA synthesis). In certain conditions prevents development of cell from G1to S phase. Interferes with DNA and RNA synthesis. See more To induce and maintain remission in acute myelocytic leukemia, acute lymphocytic leukemia, and meningeal leukemia and for treatment of lymphomas. Used in combination with other antineoplastics in established … See more Antineoplastic agent which has strong myelosuppressant activity. Immunosuppressant properties are exhibited by obliterated cell-mediated immune responses, such as delayed hypersensitivity skin … See more History of drug-induced myelosuppression; immunization procedures; pregnancy (category D) particularly during first trimester, lactation. … See more WebCytarabine C9H13N3O5 CID 6253 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more. National Institutes of Health. National Library of Medicine. National Center for Biotechnology Information. PubChem ... WebCytarabine Injection 2 g/20 mL is a sterile solution for intravenous, intrathecal or subcutaneous administration. Each mL contains 100 mg Cytarabine, USP, and the … irvine lake california